Gasdermin D inhibitor - OMass Therapeutics
Alternative Names: Gsdm D inhibitor - OMass Therapeutics; GsdmD inhibitorLatest Information Update: 11 Nov 2021
Price :
$50 *
At a glance
- Originator OMass Therapeutics
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Inflammasome inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Immunological disorders
Most Recent Events
- 04 Nov 2021 Early research in Immunological disorders in United Kingdom (unspecified route) prior to November 2021
- 03 Jan 2017 Oxford University Innovation has worldwide patent protection for method to detect complex of membrane protein bound to a therapeutic agent by mass spectrometry, in USA and Europe